Phase II Clinical Trial Evaluating the Safety and Efficacy of a Tissue Engineered Autologous Skin Substitute Reconstructive Surgery for Basal Cell Carcinoma
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
21
Tissue Engineered Human Artificial Skin: Fibrin-Hyaluronic Acid
Human artificial skin created by tissue engineering: fibrin-agarose
Skin Autograft
Hospital Costa del Sol
Marbella, Málaga, Spain
RECRUITINGHospital U. Virgen de las Nieves
Granada, Spain
RECRUITINGHospital U. Virgen de la Victoria
Málaga, Spain
RECRUITINGSafety of autologous bioengineered skin
Incidence of adverse events related to investigational medicinal products
Time frame: Through study completion, an average of 2 year
Efficacy of autologous bioengineered skin
Satisfaction of the graft assessed by doppler ultrasound and study of homeostasis
Time frame: Through study completion, an average of 2 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital U. Virgen Macarena
Seville, Spain
RECRUITING